WASHINGTON, March 10, 2026, 10:41 EDT.
UnitedHealth Group Incorporated headed into a scheduled investor appearance on Tuesday under fresh pressure after the Wall Street Journal reported that a congressional committee found seniors paid about 10% more in Medicare Part B premiums last year because of alleged overpayments to private Medicare Advantage plans. The insurer is due later on Tuesday to discuss strategy and recent results at a Barclays healthcare conference, according to a March 9 filing. 1
The timing matters. UnitedHealthcare accounted for nearly a third of Medicare Advantage plans in 2025, making parent UnitedHealth the market’s biggest private player, and the company has been trying to steady investors since warning in January that 2026 revenue would fall for the first time in decades. Medicare Advantage is the privately run version of Medicare, the federal health program for older adults and people with disabilities. 2
By 10:23 a.m. EDT, UnitedHealth shares were down about 1.4% to $281.24. Humana was off about 3.2%, CVS Health slipped about 1.2% and Elevance Health rose about 1.5%; the group has been under pressure since January, when the Trump administration proposed a 0.09% increase in 2027 Medicare Advantage payment rates. 3
The Joint Economic Committee was expected to release the report on Tuesday, the Journal said, and the committee did not immediately respond to a Reuters request for comment. The report summary did not identify any insurer by name. 1
UnitedHealth has nonetheless been central to the billing debate. A Senate Judiciary Committee report in January said the insurer used aggressive risk-adjustment coding tactics to increase Medicare Advantage reimbursements, an allegation UnitedHealth rejected; risk adjustment is the formula that pays plans more for members deemed sicker. 4
In July, UnitedHealth disclosed that it was complying with criminal and civil Justice Department requests tied to its Medicare business and said it had confidence in its practices. The company also said CMS audits had ranked its methods among the industry’s most accurate. 5
In the March 9 filing, UnitedHealth said senior leaders would discuss strategy, market positions, recent results and expectations for its end markets at the Barclays event. That comes after the company set a 2026 outlook for revenue of more than $439 billion and adjusted profit of more than $17.75 a share; Chief Executive Stephen Hemsley said it had “finished 2025 as a much stronger company.” 6
Analyst doubts have lingered. James Harlow of Novare Capital Management said in January that the Medicare payment proposal “starts to bring in worries about 2027 earnings growth,” while Morningstar’s Julie Utterback said investors hoping for a quick turnaround “may have to wait longer than hoped.” 3
Peers are not all telling the same story. Humana said in February that weaker Medicare star ratings — government quality scores that drive bonus payments — would hurt 2026 profit, while CVS kept its full-year forecast in place and Elevance also warned that elevated medical costs were still weighing on insurers. 7
A risk for UnitedHealth is that billing scrutiny and lean reimbursement could bite at the same time. If rates stay lean, UnitedHealthcare chief Tim Noel said in January the company could face “very meaningful benefit reductions,” but the 2027 rate notice is not final until April and the committee report was only due for release on Tuesday. 3
